Please login to the form below

Not currently logged in
Email:
Password:

Healthwatch England

This page shows the latest Healthwatch England news and features for those working in and with pharma, biotech and healthcare.

NHS data project delayed in England

NHS data project delayed in England

the British Medical Association (BMA), Royal College of General Practitioners (RCGP) and consumer group Healthwatch to "develop additional practical steps to promote awareness with patients and the public.". ... The move was well-received, with

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Revamping the NHS and the challenges for pharma Revamping the NHS and the challenges for pharma

    As changes reshape England’s National Health Service, how should pharma engage with the new CCGs? ... The NHS Commissioning Board will work closely with the Department of Health, Care Quality Commission and the new patient advocate group, Healthwatch ,

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Healthwatch England appoints comms and policy directors Healthwatch England appoints comms and policy directors

    Healthwatch England, the body to give patients and the general public a voice in the way health and social care services are run, has appointed two new directors to its senior ... Commenting on the appointments Dr Rake said: “I am delighted to have in

  • Healthwatch England names Katherine Rake as director Healthwatch England names Katherine Rake as director

    Dr Katherine Rake has joined recently-launched patient body Healthwatch England as its director. ... Her appointment was announced the same day as Healthwatch England's first public meeting, during which the committee discussed where the body should

More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Novasecta

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics